Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Canadian Journal of Anesthesia/Journal canadien d'anesthésie
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017

01-02-2017 | Special Article

The identification and management of substance use disorders in anesthesiologists

Authors: Lisa G. Lefebvre, MDCM, MPH, I. Michael Kaufmann, MD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 2/2017

Login to get access

Abstract

Purpose

The purpose of this article is to review current evidence for the identification and management of substance use disorders in anesthesiologists and to describe an approach to return to practice.

Principal findings

Anesthesiologists experience substance use disorders at a rate reported to be 2.7 times that of other physicians. Effective evidence-based treatment is available for physicians with substance use disorders, including anesthesiologists. Significant barriers preventing access to such treatment still exist, some of which are specific to the physician cohort. Standard of care should involve ongoing monitoring of substance use disorders in a chronic disease management paradigm. The outcomes for anesthesiologists treated and monitored for a substance use disorder are similar to those for other physicians and significantly superior to those for the general population. Return to work is possible and is most effectively managed in an occupational health risk management model.

Conclusion

The treatment of substance use disorders in anesthesiologists is effective, and a safe return to practice is possible in a majority of cases. National guidelines are needed to ensure equitable access to high-quality treatment and recovery monitoring for all Canadian physicians.
Literature
1.
2.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association Publishing; 2013. p. 481-589.CrossRef
3.
4.
Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from the brain disease model of addiction. N Engl J Med 2016; 374: 363-71.CrossRefPubMed
5.
Oreskovich MR, Kaups KL, Balch CM, et al. Prevalence of alcohol use disorders among American surgeons. Arch Surg 2012; 147: 168-74.CrossRefPubMed
6.
Oreskovich MR, Shanafelt T, Dyrbye LN, et al. The prevalence of substance use disorders in American physicians. Am J Addict 2015; 24: 30-8.CrossRefPubMed
7.
Paris RT, Canavan DI. Physician substance abuse impairment: anesthesiologists vs. other specialties. J Addict Dis 1999; 18: 1-7.CrossRefPubMed
8.
McAuliffe WE, Rohman M, Breer P, Wyshak G, Santangelo S, Magnuson E. Alcohol use and abuse in random samples of physicians and medical students. Am J Public Health 1991; 81: 177-82.CrossRefPubMedPubMedCentral
9.
Hughes PH, Brandenburg N, Baldwin DC Jr, et al. Prevalence of substance use among US physicians. JAMA 1992; 267: 2333-9.CrossRefPubMed
10.
McLellan AT, Skipper GS, Campbell M, DuPont RL. Five year outcomes in a cohort study of physicians treated for substance use disorders in the United States. BMJ 2008; 337: a2038.CrossRefPubMedPubMedCentral
11.
Oreskovich MR, Caldeiro RM. Anesthesiologists recovering from chemical dependency: can they safely return to the operating room? Mayo Clin Proc 2009; 84: 576-80.CrossRefPubMedPubMedCentral
12.
Kintz P, Villain M, Dumestre V, Cirimele V. Evidence of addiction by anesthesiologists as documented by hair analysis. Forensic Sci Int 2005; 153: 81-4.CrossRefPubMed
13.
Boulis S, Khanduja PK, Downey K, Friedman Z. Substance abuse: a national survey of Canadian residency program directors and site chiefs at university-affiliated anesthesia departments. Can J Anesth 2015; 62: 964-71.CrossRefPubMed
14.
Alexander BH, Checkoway H, Nagahama SI, Domino KB. Cause-specific mortality risks of anesthesiologists. Anesthesiology 2000; 93: 922-30.CrossRefPubMed
15.
Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Risk and outcomes of substance use disorder among anesthesiology residents: a matched cohort analysis. Anesthesiology 2015; 123: 929-36.CrossRefPubMedPubMedCentral
16.
Warner DO, Berge K, Sun H, Harman A, Hanson A, Schroeder DR. Substance use disorder among anesthesiology residents, 1975-2009. JAMA 2013; 310: 2289-96.CrossRefPubMedPubMedCentral
17.
Pelton C, Ikeda RM. The California Physicians Diversion Program’s experience with recovering anesthesiologists. J Psychoactive Drugs 1991; 23: 427-31.CrossRefPubMed
18.
Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia’s Impaired Physicians Program. Review of the first 1000 physicians: analysis of specialty. JAMA 1987; 257: 2927-30.
19.
Skipper GE, Campbell MD, Dupont RL. Anesthesiologists with substance use disorders: a 5-year outcome study from 16 state physician health programs. Anesth Analg 2009; 109: 891-6.CrossRefPubMed
20.
DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: Physicians’ Health Programs. J Subst Abuse Treat 2009; 36: 159-71.CrossRefPubMed
21.
Farber NJ, Gilibert SG, Aboff BM, Collier VU, Weiner J, Boyer EG. Physicians’ willingness to report impaired colleagues. Soc Sci Med 2005; 61: 1772-5.CrossRefPubMed
22.
23.
Earley PH. Persons in safety sensitive occupations. In: Mee-Lee D, Shulman GD, Fishman MJ, Gastfriend DR, Miller MM, Provence SM, editors. The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. 3rd ed. Carson City, NV: The Change Companies; 2013. p. 340-9.
24.
Hamza H, Bryson EO. Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy. Mayo Clin Proc 2012; 87: 260-7.CrossRefPubMedPubMedCentral
25.
Newman RG. Buprenorphine maintenance therapy in opioid-addicted health care professionals. Mayo Clin Proc 2012; 87: 804-5; author reply 806-8.
26.
Earley PH. Opioid substitution therapy for dependent health care practitioners: approach with caution. Mayo Clin Proc 2012; 87: 803-4; author reply 806-8.
27.
Hulse GK, O’Neil G, Hatton M, Paech MJ. Use of oral and implantable naltrexone in the management of the opioid impaired physician. Anaesth Intensive Care 2003; 31: 196-201.PubMed
28.
Jonas DE, Amick HR, Feltner C, et al. Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis. JAMA 2014; 311: 1889-900.CrossRefPubMed
29.
Domino KB, Hornbein TF, Polissar NL, et al. Risk factors for relapse in health care professionals with substance use disorders. JAMA 2005; 293: 1453-60.CrossRefPubMed
30.
Federation of State Physician Health Programs. Advocacy for members. Wilmington, MA: Federation of State Physician Health Programs; 2016. Available from URL: http://​www.​fsphp.​org/​advocacy (accessed October 2016).
31.
Brewster JM, Kaufmann IM, Hutchison S, MacWilliam C. Characteristics and outcomes of doctors in a substance dependence monitoring programme in Canada: prospective descriptive study. BMJ 2008; 337: a2098.CrossRefPubMedPubMedCentral
32.
Somers JM, Rezansoff SN, Moniruzzaman A. Comparative analysis of recidivism outcomes following drug treatment court in Vancouver, Canada. Int J Offender Ther Comp Criminol 2014; 58: 655-71.CrossRefPubMed
33.
Skipper GE, DuPont RL. Anesthesiologists returning to work after substance abuse treatment. Anesthesiology 2009; 110: 1422-3; author reply 1426-8.
34.
Berge KH, Seppala MD, Lanier WL. The anesthesiology community’s approach to opioid- and anesthetic-abusing personnel: time to change course. Anesthesiology 2008; 109: 762-4.CrossRefPubMed
Metadata
Title
The identification and management of substance use disorders in anesthesiologists
Authors
Lisa G. Lefebvre, MDCM, MPH
I. Michael Kaufmann, MD
Publication date
01-02-2017
Publisher
Springer US
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 2/2017
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0775-y

Other articles of this Issue 2/2017

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 2/2017 Go to the issue

Continuing Professional Development

The impaired anesthesiologist: what you should know about substance abuse

Review Article/Brief Review

Self-care as a professional imperative: physician burnout, depression, and suicide

Review Article/Brief Review

Professionalism in anesthesia

Special Article

Anesthesiology Resident Wellness Program at the University of Saskatchewan: curriculum content and delivery

Editorials

The physician at risk: disruptive behaviour, burnout, addiction, and suicide

Special Article

Anesthesiology Resident Wellness Program at the University of Saskatchewan: concept and development